title: Primary hepatic carcinoid tumor with carcinoid syndrome and carcinoid heart disease: a case report of a patient on long-term follow-up.
abstract: We report a 57-year-old woman with a primary hepatic carcinoid tumor who had been suffering from symptoms due to carcinoid syndrome and carcinoid heart disease for more than 9 years. Long-term injection of octreotide acetate was fairly effective to relieve the symptoms due to carcinoid syndrome, but its tumor contraction effect was not confirmed. The massive ascites in the follow-up period appeared to be diminished to a certain extent by timely chemotherapy including cisplatin. The patient died of multi-organ failure about 9 years after the onset of disease. Autopsy confirmed a primary hepatic carcinoid tumor with limited distant metastases.
authors.affiliation: Department of Internal Medicine, Kohryo Clinic, Takaoka, Japan.
authors.forename: Tatsuhiko
authors.initials: T
authors.lastname: Tohyama
authors.forename: Kazuhiro
authors.initials: K
authors.lastname: Matsui
authors.forename: Kiyohide
authors.initials: K
authors.lastname: Kitagawa
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001201:Ascites / Q000188:drug therapy / Q000209:etiology; D002275:Carcinoid Heart Disease / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D002276:Carcinoid Tumor / Q000150:complications* / Q000188:drug therapy / Q000473:pathology / Q000556:secondary; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D008303:Malignant Carcinoid Syndrome / Q000188:drug therapy / Q000209:etiology*; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D018931:Antineoplastic Agents, Hormonal; D015282:Octreotide